01498 PURAPHARM
Closed Add to Porfolio| Index Constituent : None | |||
| Major Shareholders | Chan Yu Ling, Abraham & Associates (57.89%) Providence Discovery Fund (8.68%) |
Sector | Health Care & Biotechnology |
|---|---|---|---|
| Web Site | http://www.purapharm.com | Tel | (852) 2840-1840 |
| info@purapharm.com | Fax | (852) 2840-0778 | |
| Related Equities | N/A | ||
| Principal Activities | Principally engaged in the research and development, production and sale of concentrated Chinese medicine granule (CCMG) products and Chinese healthcare products, plantation and trading of raw Chinese herbs, and the manufacture and sale of Traditional Chinese Medicine (TCM) decoction pieces as well as the rendering of Chinese medical diagnostic services. | ||
Consolidated List of Substantial Shareholders
| Name | Number of Shares Interested | % of Issued Share Capital (%) | Date of Last Notice Filed (Y/M/D) |
|---|---|---|---|
| 文綺慧 | 145,290,720(L) | 58.65(L) | 16/01/2019 |
| 陳宇齡 | 145,290,720(L) | 58.65(L) | 16/01/2019 |
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Complete List of Directors
| Director's Name | Number of Shares Interested | % of issued share capital (%) | Date of Last Notice Filed (Y/M/D) |
|---|---|---|---|
| 何國華 | 20,000(L) | 0.01(L) | 16/06/2018 |
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
